Last reviewed · How we verify
NCT04500405
Outcomes of Patients With Diverticulitis and Risk Factors for Recurrence
trial in Recurrence in 1,500 participants. Completed in 31 August 2023.
31 August 2023
Quick facts
| Lead sponsor | National Taiwan University Hospital |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 1,500 |
| Start date | 31 May 2020 |
| Primary completion | 31 August 2023 |
| Estimated completion | 31 August 2023 |
| Sites | 1 location across Taiwan |
Conditions studied
- Recurrence — all drugs for Recurrence →
Sponsor
National Taiwan University Hospital
Who can join
20 and older, any sex, with Recurrence. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
In the Emergency Department (ED), patients with acute diverticulitis usually present with acute abdominal pain. Sometimes, or mostly, it is an exclusive diagnosis, meaning that the diagnosis would be made after other emergent and acute abdomens are excluded. The recurrent diverticulitis cost medical burden. The studies focusing on potential risk factors of recurrent diverticulitis, especially for those after an episode of acute diverticulitis, are limited.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Colonic diverticulitis location is a risk factor for recurrence: a multicenter, retrospective cohort study in Asian patients.
Sung CW, Liu KL, Wang HP, Chen IC, et al · · 2022 · cited 2× · PMID 35296787 · DOI 10.1038/s41598-022-08708-w
Verify or expand the search:
- PubMed search for NCT04500405
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Recurrence
Currently open trials in the same condition.
- NCT07167381 — xDRIVE for Florida-based Cancer Patients · NA · recruiting
- NCT06725433 — Nissen Versus Dor Hiatal Hernia Repair · NA · recruiting
- NCT07034560 — Effectiveness of Oral Melatonin vs Oral Tranexamic Acid in the Treatment and Recurrence of Melasma · Phase 4 · active not recruiting
- NCT06542263 — Clinical Study on the Effect of CPAP on AF Recurrence After Catheter Ablation in Patients with AF and OSA · recruiting
- NCT06911736 — Effect of the Postoperative Trendelenburg Position on Chronic Subdural Hematoma Recurrence · NA · recruiting
Other National Taiwan University Hospital trials
Trials by the same sponsor.
- NCT06936917 — Timing for Computed Tomography and Post-Resuscitation Care on Short-Term Outcomes in Out-of-Hospital Cardiac Arrest · not yet recruiting
- NCT05396222 — A Prospective Study of the Safety and Efficacy of 3D-printed Non-rigid Biomimetic Implant in Cervical and Thoracolumbar · NA · not yet recruiting
- NCT07532356 — Integrating Tumor Genomics and Urinary Exosomal Proteomics to Establish a Multi-Layer Biomarker Framework for Early Risk · not yet recruiting
- NCT07317310 — The NTU JO-SMART Study · NA · not yet recruiting
- NCT07382024 — Tirzepatide to Reduce rEcurrence And Burden After Ablation of Atrial Fibrillation · NA · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04500405 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by National Taiwan University Hospital
- Last refreshed: 18 September 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04500405.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing